Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas

Carcinogenesis

Volumn 33, Issue 8, 2012, Pages 1487-1493

  Arai, Eri ^a   Chiku, Suenori ^b   Mori, Taisuke ^a   Gotoh, Masahiro ^a   Nakagawa, Tohru ^c   Fujimoto, Hiroyuki ^c   Kanai, Yae ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b MIZUHO INFORMATION AND RESEARCH INSTITUTE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASCL2 GENE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; FAM150A GENE; FAM78A GENE; FEMALE; GENE; GENOME ANALYSIS; GRM6 GENE; HUMAN; HUMAN TISSUE; KCNQ1 GENE; KHDRBS2 GENE; KIDNEY CARCINOMA; KIDNEY CORTEX; MAJOR CLINICAL STUDY; MALE; METHYLATOR PHENOTYPE; MICROARRAY ANALYSIS; NKX6 2 GENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PCDHAC1 GENE; PHENOTYPE; PRAC GENE; PRIORITY JOURNAL; RIMS4 GENE; SLC13A5 GENE; SURVIVAL RATE; TRH GENE; WNT3A GENE; ZFP42 GENE; ZNF154 GENE; ZNF540 GENE; ZNF671 GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PHENOTYPE;

EID: 84865339838     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs177     Document Type: Article

References (42)

1. Ljungberg,B. et al. (2011) The epidemiology of renal cell carcinoma. Eur. Urol., 60, 615-621.
2. Arai,E. et al. (2011) Genetic and epigenetic alterations during renal carcinogenesis. Int. J. Clin. Exp. Pathol., 4, 58-73.
3. Baldewijns,M.M. et al. (2010) VHL and HIF signalling in renal cell carcinogenesis. J. Pathol., 221, 125-138.
4. Barrett,I.P. (2010) Cancer genome analysis informatics. Methods Mol. Biol., 628, 75-102.
5. Zhang,J. et al. (2011) International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data. Database (Oxford), 2011, bar026.
6. Brannon,A.R. et al. (2010) Renal cell carcinoma: where will the state-ofthe-art lead us? Curr. Oncol. Rep., 12, 193-201.
7. Dalgliesh,G.L. et al. (2010) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature, 463, 360-363.
8. van Haaften,G. et al. (2009) Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet., 41, 521-523.
9. Varela,I. et al. (2011) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature, 469, 539-542.
10. Baylin,S.B. et al. (2011) A decade of exploring the cancer epigenome -biological and translational implications. Nat. Rev. Cancer, 11, 726-734.
11. Boumber,Y. et al. (2011) Epigenetics in cancer: what's the future? Oncology (Williston Park), 25, 220-226, 228.
12. Jones,P.A. et al. (2007) The epigenomics of cancer. Cell, 128, 683-692.
13. Kanai,Y. (2010) Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci., 101, 36-45.
14. Arai,E. et al. (2010) DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status. Epigenomics, 2, 467-481.
15. Kanai,Y. (2008) Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol. Int., 58, 544-558.
16. Kanai,Y. et al. (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis, 28, 2434-2442.
17. Arai,E. et al. (2008) Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome. Clin. Cancer Res., 14, 5531-5539.
18. Arai,E. et al. (2006) Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int. J. Cancer, 119, 288-296.
19. Arai,E. et al. (2009) Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis, 30, 214-221.
20. Arai,E. et al. (2011) Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues. Pathobiology, 78, 1-9.
21. Bibikova,M. et al. (2009) Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics, 1, 177-200.
22. Eble,J.N. et al. (2004) Renal cell carcinoma. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, pp. 10-43.
23. Fuhrman,S.A. et al. (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol., 6, 655-663.
24. Sobin,L.H. et al. (2002) International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 6th edn. Wiley-Liss, New York, pp. 193-195.
25. Kanai,T. et al. (1987) Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer, 60, 810-819.
26. Sambrook,J. et al. (2001) Molecular Cloning: A Laboratory Manual. 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 6.14-6.15.
27. Breiman,L. (2001) Random forests. Mach. Learn., 45, 5-32.
28. Morris,M.R. et al. (2010) Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics. Genome Med., 2, 59.
29. McRonald,F.E. et al. (2009) CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Mol. Cancer, 8, 31.
30. Issa,J.P. (2004) CpG island methylator phenotype in cancer. Nat. Rev. Cancer, 4, 988-993.
31. Toyota,M. et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A., 96, 8681-8686.
32. Shen,L., et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc. Natl. Acad. Sci. U.S.A., 104, 18654-18659.
33. Toyota,M. et al. (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res., 59, 5438-5442.
34. Nagashio,R. et al. (2011) Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage. Int. J. Cancer, 129, 1170-1179.
35. Gotoh,M. et al. (2011) Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification. J. Biomed. Biotechnol., 2011, 780-836.
36. Nishiyama,N. et al. (2010) Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage. Cancer Sci., 101, 231-240.
37. Arai,E. et al. (2009) Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int. J. Cancer, 125, 2854-2862.
38. Abe,M. et al. (2008) Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis. Oncology, 74, 50-60.
39. Eden,A. et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455.
40. Hansen,R.S. et al. (1999) The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl. Acad. Sci. U.S.A., 96, 14412-14417.
41. Wong,N. et al. (2001) Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am. J. Pathol. 59, 465-471.
42. Nakagawa,T. et al. (2005) DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas. J. Urol., 173, 243-246.